The Vitae Team

Spring into wellness this March! Explore our latest blog on MCAS & Tirzepatide, celebrate Women’s Month with special OneSkin SPF deals, and discover our bonus Nutrafol Clear Skin Pack. Plus, learn how easy self-scheduling can make your next visit a breeze!

Mast Cell Activation Syndrome Emerging 2025 evidence suggests Tirzepatide, originally developed for metabolic health, may help calm mast cell activation in patients with MCAS. In a recent case series, nearly 9 out of 10 treatment-resistant patients experienced meaningful symptom improvement. Could GLP-1 therapy offer new multi-system support? Read the full blog to learn more.

What if your exhaustion, weight changes, rising blood pressure, and pain all traced back to one thing — a brain stuck in survival mode? Your nervous system is built to protect you, but modern stress can keep the alarm switched on long after danger has passed. Over time, your brain learns to see threats everywhere… even when there isn’t a bear.